Literature DB >> 7999310

The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

J Kira1.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-I) is a pathogenic retrovirus associated with a chronic progressive myelopathy, termed HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP), as well as adult T-cell leukemia (ATL). A chronic inflammatory process has been implicated in HAM/TSP by a pathological study, but the exact mechanism still remains unknown. To understand better the complex mechanism of disease induction by HTLV-I, I studied the spreading pattern of HTLV-I in both peripheral blood mononuclear cells (PBMNCs) and central nervous system (CNS) tissues in patients with HAM/TSP using a quantitative polymerase chain reaction (PCR) method. My results indicated the primary event to be the efficient replication of HTLV-I in vivo, whereas HTLV-I is likely to be present in the constituent cells of the CNS in addition to the infiltrating mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999310     DOI: 10.1007/BF02780664

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  32 in total

1.  Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.

Authors:  J Kira; Y Koyanagi; T Yamada; Y Itoyama; I Goto; N Yamamoto; H Sasaki; Y Sakaki
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

2.  Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.

Authors:  K Nagata; K Ohtani; M Nakamura; K Sugamura
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

3.  High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers.

Authors:  N Tachibana; A Okayama; S Ishihara; S Shioiri; K Murai; K Tsuda; N Goya; Y Matsuo; M Essex; S Stuver
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

4.  Enhancement of human immunodeficiency virus production by natural lymphotoxin.

Authors:  T Matsuyama; Y Hamamoto; S Kobayashi; M Kurimoto; J Minowada; N Kobayashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.

Authors:  K W Selmaj; C S Raine
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

7.  Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.

Authors:  M Osame; M Matsumoto; K Usuku; S Izumo; N Ijichi; H Amitani; M Tara; A Igata
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

8.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Authors:  C L Tendler; S J Greenberg; W A Blattner; A Manns; E Murphy; T Fleisher; B Hanchard; O Morgan; J D Burton; D L Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells.

Authors:  M Sawada; A Suzumura; M Yoshida; T Marunouchi
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.

Authors:  N Ishiguro; M Abe; K Seto; H Sakurai; H Ikeda; A Wakisaka; T Togashi; M Tateno; T Yoshiki
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  1 in total

1.  Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.

Authors:  S R Himes; R Katsikeros; M F Shannon
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.